BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 22372932)

  • 1. Central administration of aminoprocalcitonin inhibits food intake and stimulates the hypothalamic-pituitary-adrenal axis in rats via the corticotrophin-releasing factor system.
    Tavares E; Maldonado R; Garcia-Martinez A; Miñano FJ
    J Neuroendocrinol; 2012 Jul; 24(7):1040-54. PubMed ID: 22372932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotrophin-releasing factor mediates vasoactive intestinal peptide-induced hypophagia and changes in plasma parameters.
    Garnica-Siqueira MC; Martins AB; Zaia DAM; Leite CM; Uchôa ET; Zaia CTBV
    Horm Behav; 2018 Sep; 105():138-145. PubMed ID: 30138609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoprocalcitonin-mediated suppression of feeding involves the hypothalamic melanocortin system.
    Tavares E; Maldonado R; Miñano FJ
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1251-62. PubMed ID: 23571710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestradiol modulates the effects of leptin on energy homeostasis by corticotrophin-releasing factor type 2 receptor.
    Marangon PB; Silva LE; Rorato R; Gomiero Alves P; Antunes-Rodrigues J; Elias LL
    J Neuroendocrinol; 2014 Nov; 26(11):796-804. PubMed ID: 25113140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraventricular nucleus administration of calcitonin gene-related peptide inhibits food intake and stimulates the hypothalamo-pituitary-adrenal axis.
    Dhillo WS; Small CJ; Jethwa PH; Russell SH; Gardiner JV; Bewick GA; Seth A; Murphy KG; Ghatei MA; Bloom SR
    Endocrinology; 2003 Apr; 144(4):1420-5. PubMed ID: 12639925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenalectomy enhances endotoxemia-induced hypophagia: higher activation of corticotrophin-releasing-factor and proopiomelanocortin hypothalamic neurons.
    Rorato R; Castro M; Borges BC; Benedetti M; Germano CM; Antunes-Rodrigues J; Elias LL
    Horm Behav; 2008 Jun; 54(1):134-42. PubMed ID: 18374921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP
    J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term infusion of brain-derived neurotrophic factor reduces food intake and body weight via a corticotrophin-releasing hormone pathway in the paraventricular nucleus of the hypothalamus.
    Toriya M; Maekawa F; Maejima Y; Onaka T; Fujiwara K; Nakagawa T; Nakata M; Yada T
    J Neuroendocrinol; 2010 Sep; 22(9):987-95. PubMed ID: 20561155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
    Larsen PJ; Tang-Christensen M; Jessop DS
    Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats.
    Al-Barazanji KA; Wilson S; Baker J; Jessop DS; Harbuz MS
    J Neuroendocrinol; 2001 May; 13(5):421-4. PubMed ID: 11328451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site of action of acute alcohol administration in stimulating the rat hypothalamic-pituitary-adrenal axis: comparison between the effect of systemic and intracerebroventricular injection of this drug on pituitary and hypothalamic responses.
    Lee S; Selvage D; Hansen K; Rivier C
    Endocrinology; 2004 Oct; 145(10):4470-9. PubMed ID: 15205375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the short chain sugar acid 2-buten-4-olide on the hypothalamo-pituitary-adrenal axis in normal and adjuvant-induced arthritic rats.
    Kawasaki M; Onaka T; Saito J; Hashimoto H; Suzuki H; Otsubo H; Fujihara H; Okimoto N; Ohnishi H; Nakamura T; Ueta Y
    J Neuroendocrinol; 2007 Jan; 19(1):54-65. PubMed ID: 17184486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin N-terminal peptide causes catabolic effects via the hypothalamus and prostaglandin-dependent pathways.
    Tavares E; Miñano FJ
    Neuroendocrinology; 2008; 88(4):316-26. PubMed ID: 18781060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-procalcitonin: central effects on feeding and energy homeostasis in rats.
    Tavares E; Maldonado R; Miñano FJ
    Endocrinology; 2007 Apr; 148(4):1891-901. PubMed ID: 17194737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of apelin on hypothalamic-pituitary-adrenal axis neuroendocrine function are mediated through corticotrophin-releasing factor- and vasopressin-dependent mechanisms.
    Newson MJ; Roberts EM; Pope GR; Lolait SJ; O'Carroll AM
    J Endocrinol; 2009 Jul; 202(1):123-9. PubMed ID: 19395447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
    Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW
    Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity.
    Ochedalski T; Subburaju S; Wynn PC; Aguilera G
    J Neuroendocrinol; 2007 Mar; 19(3):189-97. PubMed ID: 17280592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
    Kakui N; Kitamura K
    Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxin-3 stimulates the neuro-endocrine stress axis via corticotrophin-releasing hormone.
    McGowan BM; Minnion JS; Murphy KG; Roy D; Stanley SA; Dhillo WS; Gardiner JV; Ghatei MA; Bloom SR
    J Endocrinol; 2014 May; 221(2):337-46. PubMed ID: 24578294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.